Show simple item record

dc.contributor.authorHowell, Anthonyen
dc.date.accessioned2010-03-24T10:04:35Z
dc.date.available2010-03-24T10:04:35Z
dc.date.issued1997-07
dc.identifier.citationNew endocrine agents. 1997, 23 Suppl 1:S49-57 Cancer Treat. Rev.en
dc.identifier.issn0305-7372
dc.identifier.pmid9377602
dc.identifier.urihttp://hdl.handle.net/10541/94814
dc.language.isoenen
dc.subjectBreast Canceren
dc.subjectOestrogen Antagonistsen
dc.subjectOestrogen Receptorsen
dc.subject.meshAntineoplastic Agents, Hormonal
dc.subject.meshAromatase Inhibitors
dc.subject.meshBreast Neoplasms
dc.subject.meshChemotherapy, Adjuvant
dc.subject.meshEstrogen Antagonists
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshReceptors, Estrogen
dc.titleNew endocrine agents.en
dc.typeArticleen
dc.contributor.departmentChristie Hospital, Withington, Manchester, U.K.en
dc.identifier.journalCancer Treatment Reviewsen


This item appears in the following Collection(s)

Show simple item record